Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CSPC Pharmaceutical Group Limited
  6. Summary
    1093   HK1093012172

CSPC PHARMACEUTICAL GROUP LIMITED

(1093)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
10/08/2021 10/11/2021 10/12/2021 10/15/2021 10/18/2021 Date
9.17 9.22 9 8.65 8.65 Last
32762690 20040770 37442230 71394230 65828990 Volume
-0.86% +0.55% -2.39% -3.89% 0.00% Change
Estimated financial data (e)
Sales 2021 33 795 M 4 344 M 4 344 M
Net income 2021 6 763 M 869 M 869 M
Net cash position 2021 11 471 M 1 475 M 1 475 M
P/E ratio 2021 15,3x
Yield 2021 1,95%
Sales 2022 39 386 M 5 063 M 5 063 M
Net income 2022 7 693 M 989 M 989 M
Net cash position 2022 15 458 M 1 987 M 1 987 M
P/E ratio 2022 13,5x
Yield 2022 2,09%
Capitalization 103 B 13 294 M 13 293 M
EV / Sales 2021 2,72x
EV / Sales 2022 2,23x
Nbr of Employees 23 300
Free-Float 70,6%
More Financials
Company
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows: - drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%); - vitamin C (10.1%); - antibiotics (6.2%); - other (5%): including anhydrous and raw caffeine. Net sales are distributed geographically as follows: China... 
Sector
Pharmaceuticals
Calendar
11/22Earnings Release
More about the company
Ratings of CSPC Pharmaceutical Group Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about CSPC PHARMACEUTICAL GROUP LIMITED
10/17CSPC PHARMACEUTICAL : Chinese Regulators OK Registration of CSPC Pharmaceutical's Venous T..
MT
10/15Hong Kong Hang Seng Up 1.5% On Auto, Rebounding Tech Issues
MT
10/15GEELY AUTOMOBILE : Hong Kong shares rise after strong earnings boost Wall Street
RE
09/28Hong Kong Hang Seng Up 1.2% as Tech Gains, Property Issues Surge
MT
09/27Hong Kong Hang Seng Inches Higher; Property and Tech Sectors Still Declining
MT
09/22KEYMED BIOSCIENCES : Partners With CSPC Pharmaceutical to Develop Potential Nervous System..
MT
09/16CSPC Pharmaceutical Group Limited Declares Interim Dividend for the Year 2021, Payable ..
CI
09/10CSPC PHARMACEUTICAL GROUP LIMITED : Ex-dividend day for interim dividend
FA
09/03CSPC PHARMACEUTICAL : Secures Regulatory Nod for Phase 1 Clinical Trial of Cancer Treatmen..
MT
09/02CSPC PHARMACEUTICAL : Secures Registration Approval for Influenza Treatment in China
MT
09/01CSPC PHARMACEUTICAL : Voluntary announcement - "oseltamivir phosphate capsules" obtains dr..
PU
08/27HANG SENG : Hong Kong Hang Seng See-Saws Flat, as Tech Shares Slip
MT
08/27CSPC PHARMACEUTICAL : H1 Profit Rises 32% as Higher Drug Sales Boost Revenue
MT
08/26CSPC Pharmaceutical Group Limited Declares an Interim Dividend for 2021, Payable on 8 O..
CI
08/26CSPC Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June..
CI
More news
News in other languages on CSPC PHARMACEUTICAL GROUP LIMITED
10/15Le Hang Seng de Hong Kong progresse de 1,5 % grâce à l'automobile et au rebond des vale..
09/28Le Hang Seng de Hong Kong progresse de 1,2 % grâce aux gains technologiques et à la hau..
09/27Le Hang Seng de Hong Kong grimpe, mais les secteurs de l'immobilier et de la technologi..
09/16CSPC Pharmaceutical Group Limited déclare un dividende intérimaire pour l'année 2021, p..
08/27Le Hang Seng de Hong Kong reste plat, les valeurs technologiques dégringolent
More news
Analyst Recommendations on CSPC PHARMACEUTICAL GROUP LIMITED
More recommendations
Chart CSPC PHARMACEUTICAL GROUP LIMITED
Duration : Period :
CSPC Pharmaceutical Group Limited Technical Analysis Chart | 1093 | HK1093012172 | MarketScreener
Technical analysis trends CSPC PHARMACEUTICAL GROUP LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Last Close Price 8,65 HKD
Average target price 13,71 HKD
Spread / Average Target 58,5%
EPS Revisions
Managers and Directors
Dong Chen Cai Chairman & Co-Chief Executive Officer
Cuilong Zhang Vice Chairman & Co-Chief Executive Officer
Bo Wang Independent Non-Executive Director
Chuan Chen Independent Non-Executive Director
Chun Kwok Au Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
CSPC PHARMACEUTICAL GROUP LIMITED9.08%13 294
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY40.89%215 657